Showing results (21-30 of 28) with videos related to
Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
Hepatology (Baltimore, Md.)|January 7, 2012
Elastin accumulation is regulated at the level of degradation by macrophage metalloelastase (MMP-12) during experimental liver fibrosisAntonella Pellicoro, Rebecca L Aucott, Prakash Ramachandran, et al.Trials|December 18, 2019
ELECtric Tibial nerve stimulation to Reduce Incontinence in Care homes: protocol for the ELECTRIC randomised trialJ Booth, L Aucott, S Cotton, et al.Hepatology (Baltimore, Md.)|December 19, 2017
11Beta-hydroxysteroid dehydrogenase-1 deficiency or inhibition enhances hepatic myofibroblast activation in murine liver fibrosisXiantong Zou, Prakash Ramachandran, Timothy J Kendall, et al.Scientific Reports|September 9, 2017
In search of a small molecule agonist of the relaxin receptor RXFP1 for the treatment of liver fibrosisAndrew McBride, Anna M Hoy, Mark J Bamford, et al.Hepatology (Baltimore, Md.)|July 23, 2013
Relaxin modulates human and rat hepatic myofibroblast function and ameliorates portal hypertension in vivoJonathan A Fallowfield, Annette L Hayden, Victoria K Snowdon, et al.Proceedings of the National Academy of Sciences of the United States of America|October 27, 2012
Differential Ly-6C expression identifies the recruited macrophage phenotype, which orchestrates the regression of murine liver fibrosisPrakash Ramachandran, Antonella Pellicoro, Madeleine A Vernon, et al.Journal of Immunology (Baltimore, Md. : 1950)|December 22, 2017
The STAT3-IL-10-IL-6 Pathway Is a Novel Regulator of Macrophage Efferocytosis and Phenotypic Conversion in Sterile Liver InjuryLara Campana, Philip J Starkey Lewis, Antonella Pellicoro, et al.Plos Medicine|March 1, 2017
Serelaxin as a potential treatment for renal dysfunction in cirrhosis: Preclinical evaluation and results of a randomized phase 2 trialVictoria K Snowdon, Neil J Lachlan, Anna M Hoy, et al.Pageof 3